A Randomized, Double-Blind, Placebo-Controlled Pilot Clinical Study on ColdZyme<sup>®</sup> Mouth Spray against Rhinovirus-Induced Common Cold

Journals Menu

Follow SCIRP

ISSN Print: 2163-940X
ISSN Online: 2163-9418
www.scirp.org/journal/ojrd
E-mail: ojrd@scirp.org

Citations h5-index & Ranking*

"A Randomized, Double-Blind, Placebo-Controlled Pilot Clinical Study on ColdZyme^® Mouth Spray against Rhinovirus-Induced Common Cold"
written by Mats Clarsund, Marcus Fornbacke, Lena Uller, Sebastian L. Johnston, Cecilia Ahlström Emanuelsson,
published by Open Journal of Respiratory Diseases, Vol.7 No.4, 2017

has been cited by the following article(s):

[1]	Early intervention with ColdZyme mouth spray after self-diagnosis of common cold: a randomized, double-blind, placebo-controlled study
	PloS one, 2023

[2]	Early intervention with a glycerol throat spray containing cold-adapted cod trypsin after self-diagnosis of common cold: A randomised trial
	Plos one, 2022

[3]	Does Trypsin Oral Spray (Viruprotect®/ColdZyme®) Protect against COVID-19 and Common Colds or Induce Mutation? Caveats in Medical Device Regulations in the …
	2021

[4]	ColdZyme® Mouth Spray reduces duration of upper respiratory tract infection symptoms in endurance athletes under free living conditions.
	2020

[5]	ColdGuard™ in the prevention and management of the common cold
	2020

[6]	Inactivation of SARS‐CoV‐2 and HCoV‐229E in vitro by ColdZyme® a medical device mouth spray against the common cold
	2020

[7]	Coldzyme® Mouth Spray reduces duration of upper respiratory tract infection symptoms in endurance athletes under free living conditions
	2020

[8]	COLDZYME MUNSPRAY
	2019

[9]	User Experience of ColdZyme Mouth Spray against Common Cold in Competitive Athletes
	2018

[10]	Prevención de catarros y resfriados
	2017

[11]	A medical device forming a protective barrier that deactivates four major common cold viruses
	Virology: Research & Reviews, 2017

[1]	Early intervention with ColdZyme mouth spray after self-diagnosis of common cold: A randomized, double-blind, placebo-controlled study PLOS ONE, 2023 DOI:10.1371/journal.pone.0279204

[2]	Coldzyme® Mouth Spray reduces duration of upper respiratory tract infection symptoms in endurance athletes under free living conditions European Journal of Sport Science, 2021 DOI:10.1080/17461391.2020.1771429

[3]	Does Trypsin Oral Spray (Viruprotect®/ColdZyme®) Protect against COVID-19 and Common Colds or Induce Mutation? Caveats in Medical Device Regulations in the European Union International Journal of Environmental Research and Public Health, 2021 DOI:10.3390/ijerph18105066

[4]	Coldzyme® Mouth Spray reduces duration of upper respiratory tract infection symptoms in endurance athletes under free living conditions European Journal of Sport Science, 2020 DOI:10.1080/17461391.2020.1771429

Follow SCIRP